1. Early diagnosis of tuberculous peritonitis in peritoneal dialysis patients using the T-SPOT test.
- Author
-
Okubo N, Suwabe T, Yamanouchi M, Ikuma D, Mizuno H, Oba Y, Miki K, Yokoyama T, Ishii Y, Sawa N, Nakamura Y, Takaya H, and Ubara Y
- Subjects
- Humans, Male, Middle Aged, Antitubercular Agents therapeutic use, Antitubercular Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Anti-Bacterial Agents administration & dosage, Interferon-gamma Release Tests methods, Peritonitis, Tuberculous diagnosis, Peritonitis, Tuberculous drug therapy, Early Diagnosis, Mycobacterium tuberculosis isolation & purification, Peritoneal Dialysis, Continuous Ambulatory adverse effects
- Abstract
A 49-year-old man was admitted with peritonitis nine months after starting continuous ambulatory peritoneal dialysis (CAPD) for kidney failure. Ceftazidime and cefazolin were started. Peritoneal dialysate culture was negative for bacteria, but antibiotic treatment was continued because peritonitis improved. Twenty days later, the patient was discharged with no signs of peritonitis. However, 40-day culture of the original peritoneal dialysate detected Mycobacterium tuberculosis, and peritonitis recurred, leading to readmission. A T-SPOT test was performed and was positive in 4 days. Anti-tuberculosis therapy was started, which cured the peritonitis. The T-SPOT test may enable early diagnosis of tuberculosis., Competing Interests: Declarations. Conflict of interest: The authors have declared that no Conflict of interest exists. Ethics approval: The present report was produced in conformity with the Declaration of Helsinki, and the patient gave his written consent for this case report to be published., (© 2024. The Author(s), under exclusive licence to Japanese Society of Nephrology.)
- Published
- 2024
- Full Text
- View/download PDF